This approval makes Eli Lillys oral GLP-1 receptor agonist, to be marketed as Foundayo, the second GLP-1 drug available in pill form, after Wegovy, which gained approval in December 2025
There are also effects on satiety via actions within the brain
Khan serves on an advisory board for Bayer and Novartis
Calcium and BoneRelated Nutrients Rapid weight loss is associated with bone loss as well as reduced bone mineral density and many adults with overweight or obesity already fall short of calcium recommendations
Extended under-eating can lead to nutrient gaps and other health concerns
Notably, the diversification of gut microbiota resulting from metformin treatment was observed following oral administration in mice, a phenomenon not replicated with intraperitoneal injection (Broadfield et al., 2022)